Blog

Cannabis & the Law

Foley Hoag has been at the forefront of the medical and adult-use cannabis industry since the very early stages of its regulation and legalization in specific U.S. states and beyond. Our leading, full-service Cannabis Practice is comprised of attorneys with unique insight and experience to assist cannabis and cannabis-related operators and investors with all aspects of their business. Our practice is national and international in scope, as we represent cannabis clients in transactions in a variety of states and Canada.

UPDATE: DEA Publishes Registration Applications for Medical Marijuana Manufacturers, Distributors, and Analytical Labs
Blog October 08, 2026
In the past 48 hours, DEA has now published registration links specific to medical marijuana manufacturers, distributors, and analytical labs on its Diversion Control Division online registration portal…
Federal Court Declares New Jersey's Cannabis Labor Peace Agreement Mandate Preempted by Federal Law: What Every Licensed Operator Needs to Know
Blog August 18, 2026
On August 10, 2026, the United States District Court for the District of New Jersey entered final judgment in Curaleaf Holdings, Inc. v. New Jersey Cannabis Regulatory Commission, No. 25-cv-16397 (D.N.J.), declaring that the labor peace agreement ("LPA") requirement in the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act ("CREAMMA") and its implementing regulations is preempted by the National Labor Relations Act ("NLRA") as applied against plaintiff Curaleaf…
Rhode Island CCC Application Reset
Blog July 28, 2026
Rhode Island's adult-use cannabis retail licensing process has been the subject of a roller coaster ride in the last half year since the submittal deadline, and the Rhode Island Cannabis Control Commission’s (“CCC” or “Commission”) Friday, July 24, 2026 update gave the clearest picture yet of not just where things stand, but most importantly, where this process is  headed…
DEA Inspections and Information Requests: What You Need to Know
Blog July 24, 2026
While the medical marijuana rescheduling order made clear that the Drug Enforcement Agency (“DEA”) would prioritize the review of medical marijuana applications submitted during the first sixty (60) days of the application window, we are watching now the details and process of that review come into picture…
Minnesota Governor Walz Signs Landmark Cannabis Omnibus Bill, Reshaping State’s Cannabis Industry
Blog May 28, 2026
On May 26, 2026, the Minnesota Governor Tim Walz signed into law the 2026 Omnibus Cannabis Bill…
DEA Application Portal for Expedited Registration of Medical Marijuana Dispensaries is Now Open
Blog April 30, 2026
As previewed in our recent blog posts (here and here), the DEA application portal for expedited registration of medical marijuana dispensaries is now open and businesses are currently able to submit applications…
DOJ Immediately Reschedules State-Licensed Medical Cannabis to Schedule III — and Restarts the Clock
Blog April 23, 2026
After years of false starts, the federal government has finally moved on cannabis rescheduling — at least partially. On April 23, 2026, the Department of Justice issued an Order immediately placing cannabis “subject to a state medical marijuana license” in Schedule III of the Controlled Substances Act (CSA). Simultaneously, the DEA announced an expedited administrative hearing — set to begin June 29, 2026 — to address the broader rescheduling of all cannabis from Schedule I to Schedule III…
New Jersey Legislative Changes Implement Growth and Opportunity for Cannabis Marketplace
Blog January 14, 2026
2025 ended and 2026 commenced with a flurry of legislative activity in New Jersey touching on cannabis businesses…
Media Reports President Trump to Issue Impending Executive Order on Cannabis Rescheduling: Legal Process, Limitations, and Next Steps
Blog December 16, 2025
According to numerous media reports, President Donald Trump is strongly considering issuing an executive order directing federal agencies to resume the process rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act…
1 of 6

About Our Blog

Foley Hoag has been at the forefront of the medical and adult-use cannabis industry since the very early stages of its regulation and legalization in specific U.S. states and beyond. Our leading, full-service Cannabis Practice is comprised of attorneys with unique insight and experience to assist cannabis and cannabis-related operators and investors with all aspects of their business. Our practice is national and international in scope, as we represent cannabis clients in transactions in a variety of states and Canada.

We have developed this blog specifically to track the regulatory framework for the cannabis industry and provide insight on legal issues of concern to cannabis businesses.

Our focus will include reporting legal developments and providing commentary on:

  • Legislative developments;
  • Regulatory and policy enactments;
  • The appointment and constitution of the Cannabis Control Commission;
  • The impact of recreational cannabis regulation on the existing medical marijuana regulatory framework;
  • Developments in federal law;
  • Municipal issues;
  • Corporate considerations;
  • Employment issues; and
  • Policy matters.